Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DOXORUBICIN vs DOXYCYCLINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DOXORUBICIN vs DOXYCYCLINE: Safety Overview

Metric DOXORUBICIN DOXYCYCLINE
Total FAERS Reports 82,754 17,741
Deaths Reported 15,653 1,653
Death Rate 18.9% 9.3%
Hospitalizations 28,630 5,618
Average Patient Age 50.5 yrs 51.0 yrs
% Female Patients 53.9% 61.3%
FDA Approval Date Approved Prior to Jan 1, 1982 Approved Prior to Jan 1, 1982
Manufacturer Hikma Pharmaceuticals USA Inc. NuCare Pharmaceuticals,Inc.
Route INTRAVENOUS ORAL
Marketing Status Discontinued Discontinued